Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Non-Current Deferred Tax Liability (2016 - 2024)

Lifecore Biomedical, Inc. \De\ (LFCR) has 14 years of Non-Current Deferred Tax Liability data on record, last reported at $552000.0 in Q4 2024.

  • For Q4 2024, Non-Current Deferred Tax Liability rose 32.69% year-over-year to $552000.0; the TTM value through Nov 2024 reached $552000.0, up 32.69%, while the annual FY2024 figure was $543000.0, 42.89% up from the prior year.
  • Non-Current Deferred Tax Liability reached $552000.0 in Q4 2024 per LFCR's latest filing, up from $443000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $13.6 million in Q2 2020 and bottomed at $10000.0 in Q4 2022.
  • Average Non-Current Deferred Tax Liability over 5 years is $3.2 million, with a median of $579500.0 recorded in 2024.
  • Peak YoY movement for Non-Current Deferred Tax Liability: crashed 99.17% in 2022, then skyrocketed 4060.0% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $6.7 million in 2020, then plummeted by 82.19% to $1.2 million in 2021, then plummeted by 99.17% to $10000.0 in 2022, then surged by 4060.0% to $416000.0 in 2023, then soared by 32.69% to $552000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $552000.0 in Q4 2024, $443000.0 in Q3 2024, and $543000.0 in Q2 2024.